FEATURED ARTICLES

Speeding Research With Data Mining Expertise Speeding Research With Data Mining Expertise

According to The STM Report (2015), more than 2.5 million peer-reviewed articles are published in scholarly journals each year. PubMed alone contains more than 25 million citations for biomedical journal articles from MEDLINE. The amount and availability of content for clinical researchers has never been greater – but finding the right articles to use is becoming more difficult.

  • Ed Miseta
    Economic Freedom And Innovation – Why We Should All Be Worried

    Are you concerned about the ranking of the United States in regard to the Economic Freedom of the World Annual Report? If not, you should be – and here’s why. Economic freedom is not just about politics or tariffs or regulations. It is about people. It is about being able to work where you want, when you want, trade the way you want, and live in a society where you are protected from others. It is also about the level of your health and your life expectancy.

  • Is Innovation In Chromatography Losing Steam?

    BIO innovation notes - Both end users and vendors are investing less.

  • Genzyme: Helping Sanofi Break Free Of Blockbuster Medicines

    Sanofi’s 2009 annual report indicated that the company needed to transition away from a reliance on blockbuster medicines, instead, optimize its approach to R&D, which is something Genzyme could help with.

More Featured Articles

WHITE PAPERS & CASE STUDIES

More White Papers & Case Studies

SERVICES & PRODUCTS

Medical & Regulatory Affairs

Taking new products successfully through clinical development, submission and approval can be a difficult, expensive and lengthy process. SynteractHCR’s medical regulatory affairs group offers a wide range of services that spans the full range of product development, including training, performed by senior regulatory professionals with experience in pharmaceutical, diagnostic, device and biotechnology industries. Our medical regulatory affairs team is here to deliver on aggressive timelines and control costs, while ensuring compliance and patient safety.

Post-Marketing Drug Safety

With our sophisticated full-service approach to post-marketing event handling (medical inquires, product quality complaints and adverse events), clients are assured that calls received from healthcare providers and / or patients and handled effectively and data obtained during a reported event are captured, stored and reported in a manner that not only ties all of the events together reported on a single call, but provides the best possible experience for the consumer.

Clinical Product Safety

Given the complex nature of medicines and the associated unpredictability of adverse events, pharmacovigilance activities play a critical role in managing the risks posed to the general population.

Pharmacovigilance Services
Norwich Clinical Services offers comprehensive pharmacovigilance services for pre-marketing product safety, post-marketing surveillance and data analysis.
Pharmacovigilance

It's peace of mind -- and more. Global Safety AdvantageSM is an enhanced and seamless Global Safety Surveillance and Pharmacovigilance program.

Product Safety And Pharmacovigilance

A team of physicians, nurses, and pharmacists
Throughout the life cycle of the program, Product Safety ensures timelines are met in global safety reporting in clinical trials, supports and educates site staff, and provides a safety profile through management and analysis of the safety data as part of their pharmacovigilance services. Our experienced, highly trained safety team is composed of physicians, registered nurses, clinical pharmacists, and medical technologists. These safety and surveillance experts specialize in the collection, evaluation, and submission of safety data in clinical trials. The cornerstone of all of the Product Safety services is the concise and rapid exchange of safety information among all parties.

More Services & Products

NEWS

More News